John F. Neylan - Net Worth and Insider Trading
John F. Neylan Net Worth
The estimated net worth of John F. Neylan is at least $533,357 dollars as of 2024-11-08. John F. Neylan is the Chief Medical Officer of Keryx Biopharmaceuticals Inc and owns about 148,279 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $498,217. John F. Neylan is also the See Remarks of Angion Biomedica Corp and owns about 3,514 shares of Angion Biomedica Corp (ANGN) stock worth over $35,140. Details can be seen in John F. Neylan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F. Neylan has not made any transactions after 2021-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John F. Neylan
John F. Neylan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John F. Neylan owns 2 companies in total, including Angion Biomedica Corp (ANGN) , and Elicio Therapeutics Inc (ELTX) .
Click here to see the complete history of John F. Neylan’s form 4 insider trades.
Insider Ownership Summary of John F. Neylan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANGN | Angion Biomedica Corp | 2021-12-20 | See Remarks |
| ELTX | Elicio Therapeutics Inc | 2021-02-04 | See Remarks |
John F. Neylan Latest Holdings Summary
John F. Neylan currently owns a total of 2 stocks. Among these stocks, John F. Neylan owns 148,279 shares of Keryx Biopharmaceuticals Inc (KERX) as of November 15, 2018, with a value of $498,217 and a weighting of 93.41%. John F. Neylan also owns 3,514 shares of Angion Biomedica Corp (ANGN) as of December 20, 2021, with a value of $35,140 and a weighting of 6.59%.
Latest Holdings of John F. Neylan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KERX | Keryx Biopharmaceuticals Inc | 2018-11-15 | 148,279 | 3.36 | 498,217 |
| ANGN | Angion Biomedica Corp | 2021-12-20 | 3,514 | 10.00 | 35,140 |
Holding Weightings of John F. Neylan
John F. Neylan Form 4 Trading Tracker
According to the SEC Form 4 filings, John F. Neylan has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 1,156 shares on November 15, 2018, which brought John F. Neylan around $3,202.
According to the SEC Form 4 filings, John F. Neylan has made a total of 9 transactions in Angion Biomedica Corp (ANGN) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Angion Biomedica Corp is the sale of 36 shares on December 20, 2021, which brought John F. Neylan around $938.
Insider Trading History of John F. Neylan
- 1
John F. Neylan Trading Performance
GuruFocus tracks the stock performance after each of John F. Neylan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F. Neylan is -24.3%. GuruFocus also compares John F. Neylan's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F. Neylan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John F. Neylan's insider trading performs compared to the benchmark.
Performance of John F. Neylan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.4 | | | | | |
| Relative Return to S&P 500(%) | -21.41 | | | | | |
John F. Neylan Ownership Network
Ownership Network List of John F. Neylan
Ownership Network Relation of John F. Neylan
John F. Neylan Owned Company Details
What does Angion Biomedica Corp do?
Who are the key executives at Angion Biomedica Corp?
John F. Neylan is the See Remarks of Angion Biomedica Corp. Other key executives at Angion Biomedica Corp include director & See Remarks Jay Venkatesan , See Remarks Gregory S Curhan , and See Remarks Jennifer J Rhodes .
Angion Biomedica Corp (ANGN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Angion Biomedica Corp (ANGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Angion Biomedica Corp (ANGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Angion Biomedica Corp (ANGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Angion Biomedica Corp Insider Transactions
John F. Neylan Mailing Address
Above is the net worth, insider trading, and ownership report for John F. Neylan. You might contact John F. Neylan via mailing address: 750 Lexington Avenue, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
